Abaxis Stock Price, News & Analysis (NASDAQ:ABAX)

$48.04 0.27 (0.57 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$47.77
Today's Range$47.53 - $48.45
52-Week Range$43.66 - $55.44
Volume320,600 shs
Average Volume124,274 shs
Market Capitalization$1.08 billion
P/E Ratio39.48
Dividend Yield1.35%
Beta0.86

About Abaxis (NASDAQ:ABAX)

Abaxis logoAbaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Receive ABAX News and Ratings via Email

Sign-up to receive the latest news and ratings for ABAX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ABAX
CUSIP00256710
Phone510-675-6500

Debt

Debt-to-Equity RatioN/A
Current Ratio6.34%
Quick Ratio5.28%

Price-To-Earnings

Trailing P/E Ratio39.48
Forward P/E Ratio44.48
P/E GrowthN/A

Sales & Book Value

Annual Sales$227.22 million
Price / Sales4.80
Cash Flow$1.66 per share
Price / Cash28.88
Book Value$11.81 per share
Price / Book4.07

Profitability

Trailing EPS$1.20
Net Income$32.71 million
Net Margins11.98%
Return on Equity10.18%
Return on Assets8.84%

Miscellaneous

Employees584
Outstanding Shares22,700,000

Abaxis (NASDAQ:ABAX) Frequently Asked Questions

What is Abaxis' stock symbol?

Abaxis trades on the NASDAQ under the ticker symbol "ABAX."

How often does Abaxis pay dividends? What is the dividend yield for Abaxis?

Abaxis announced a quarterly dividend on Tuesday, October 24th. Stockholders of record on Friday, December 1st will be paid a dividend of $0.16 per share on Friday, December 15th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date is Thursday, November 30th. This is a positive change from Abaxis's previous quarterly dividend of $0.14. View Abaxis' Dividend History.

How will Abaxis' stock buyback program work?

Abaxis declared that its Board of Directors has approved a stock buyback program on Wednesday, October 25th 2017, which permits the company to repurchase $21,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's leadership believes its stock is undervalued.

How were Abaxis' earnings last quarter?

Abaxis Inc (NASDAQ:ABAX) announced its earnings results on Tuesday, October, 24th. The medical research company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.02. The medical research company earned $58.90 million during the quarter, compared to the consensus estimate of $60.85 million. Abaxis had a net margin of 11.98% and a return on equity of 10.18%. Abaxis's revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.34 earnings per share. View Abaxis' Earnings History.

When will Abaxis make its next earnings announcement?

Abaxis is scheduled to release their next quarterly earnings announcement on Wednesday, January, 24th 2018. View Earnings Estimates for Abaxis.

Where is Abaxis' stock going? Where will Abaxis' stock price be in 2017?

5 equities research analysts have issued twelve-month target prices for Abaxis' shares. Their forecasts range from $39.00 to $56.50. On average, they anticipate Abaxis' share price to reach $47.63 in the next twelve months. View Analyst Ratings for Abaxis.

Who are some of Abaxis' key competitors?

Who are Abaxis' key executives?

Abaxis' management team includes the folowing people:

  • Clinton H. Severson, Chairman of the Board, Chief Executive Officer (Age 69)
  • Donald Peter Wood, President, Chief Operating Officer (Age 65)
  • Ross Taylor, Chief Financial Officer, Vice President - Finance, Secretary (Age 53)
  • Kenneth P. Aron Ph.D., Chief Technology Officer (Age 64)
  • Craig M. Tockman, Vice President - Animal Health Sales and Marketing for North America (Age 57)
  • Achim Henkel, Managing Director of Abaxis Europe GmbH (Age 59)
  • Vernon Edward Altman, Lead Independent Director (Age 71)
  • Richard J. Bastiani Ph.D., Independent Director (Age 74)
  • Michael D. Casey, Independent Director (Age 71)
  • Henk J. Evenhuis, Independent Director (Age 74)

Who owns Abaxis stock?

Abaxis' stock is owned by a number of of retail and institutional investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (15.44%), Dimensional Fund Advisors LP (3.01%), Wells Fargo & Company MN (2.80%), New York State Common Retirement Fund (1.73%), Copeland Capital Management LLC (1.47%) and Bank of New York Mellon Corp (1.38%). Company insiders that own Abaxis stock include Achim Henkel, Clinton Severson, Donald Peter Wood, Henk Evenhuis, Kenneth Aron, Prithipal Singh, Richard Bastiani and Vernon E Altman. View Institutional Ownership Trends for Abaxis.

Who sold Abaxis stock? Who is selling Abaxis stock?

Abaxis' stock was sold by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, New York State Common Retirement Fund, Schwab Charles Investment Management Inc., Bank of New York Mellon Corp, California State Teachers Retirement System, Great West Life Assurance Co. Can, State of Tennessee Treasury Department and Principal Financial Group Inc.. Company insiders that have sold Abaxis company stock in the last year include Achim Henkel and Richard Bastiani. View Insider Buying and Selling for Abaxis.

Who bought Abaxis stock? Who is buying Abaxis stock?

Abaxis' stock was acquired by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Russell Investments Group Ltd., JPMorgan Chase & Co., Dimensional Fund Advisors LP, First Trust Advisors LP, Rhumbline Advisers, Stevens Capital Management LP and OxFORD Asset Management LLP. View Insider Buying and Selling for Abaxis.

How do I buy Abaxis stock?

Shares of Abaxis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Abaxis' stock price today?

One share of Abaxis stock can currently be purchased for approximately $48.04.

How big of a company is Abaxis?

Abaxis has a market capitalization of $1.08 billion and generates $227.22 million in revenue each year. The medical research company earns $32.71 million in net income (profit) each year or $1.20 on an earnings per share basis. Abaxis employs 584 workers across the globe.

How can I contact Abaxis?

Abaxis' mailing address is 3240 WHIPPLE ROAD, UNION CITY CA, 94587. The medical research company can be reached via phone at 510-675-6500 or via email at [email protected]


MarketBeat Community Rating for Abaxis (ABAX)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  126 (Vote Outperform)
Underperform Votes:  250 (Vote Underperform)
Total Votes:  376
MarketBeat's community ratings are surveys of what our community members think about Abaxis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Abaxis (NASDAQ:ABAX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 1.751.751.781.89
Ratings Breakdown: 3 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $45.90$45.90$46.70$47.30
Price Target Upside: 4.83% downside6.93% downside0.81% downside6.28% downside

Abaxis (NASDAQ:ABAX) Consensus Price Target History

Price Target History for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ:ABAX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/1/2017AegisReiterated RatingHoldHighView Rating Details
10/27/2017Canaccord GenuityReiterated RatingHold$46.00 -> $47.00N/AView Rating Details
10/25/2017Bank of AmericaLower Price TargetUnderperform$42.00 -> $39.00N/AView Rating Details
7/14/2017Stifel NicolausReiterated RatingHold$48.00LowView Rating Details
2/1/2017Seaport Global SecuritiesUpgradeBuyN/AView Rating Details
11/30/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
8/16/2016Credit Suisse GroupReiterated RatingSell$39.00N/AView Rating Details
7/22/2016Feltl & Co.DowngradeHold -> SellN/AView Rating Details
4/1/2016CL KingInitiated CoverageNeutralN/AView Rating Details
1/29/2016Piper Jaffray CompaniesLower Price TargetNeutral$49.00 -> $45.00N/AView Rating Details
(Data available from 12/15/2015 forward)

Earnings

Abaxis (NASDAQ:ABAX) Earnings History and Estimates Chart

Earnings by Quarter for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ ABAX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/24/2018$0.26N/AView Earnings Details
10/24/2017Q2 2018$0.27$0.29$60.85 million$58.90 millionViewN/AView Earnings Details
7/27/2017Q1 2018$0.33$0.28$60.37 million$58.26 millionViewN/AView Earnings Details
4/27/2017Q4 2017$0.33$0.33$58.04 million$58.20 millionViewN/AView Earnings Details
1/26/2017Q317$0.31$0.30$54.36 million$52.80 millionViewN/AView Earnings Details
10/25/2016Q217$0.35$0.34$60.69 million$58.60 millionViewListenView Earnings Details
7/21/2016Q117$0.32$0.30$58.70 million$57.70 millionViewListenView Earnings Details
4/28/2016Q416$0.32$0.36$56.62 million$57.00 millionViewListenView Earnings Details
1/28/2016Q316$0.33$0.35$58.52 million$52.90 millionViewListenView Earnings Details
10/27/2015Q216$0.32$0.34$56.20 million$56.00 millionViewListenView Earnings Details
7/23/2015Q116$0.28$0.31$53.75 million$53.10 millionViewListenView Earnings Details
4/30/2015Q415$0.27$0.17$55.62 million$52.00 millionViewN/AView Earnings Details
1/29/2015Q315$0.25$0.26$51.70 million$59.50 millionViewN/AView Earnings Details
10/21/2014Q215$0.23$0.24$50.55 million$53.90 millionViewListenView Earnings Details
7/24/2014Q115$0.19$0.21$46.95 million$47.50 millionViewN/AView Earnings Details
4/24/2014Q414$0.19$0.17$45.74 million$42.04 millionViewN/AView Earnings Details
1/31/2014Q314$0.20$0.14$49.47 million$40.00 millionViewN/AView Earnings Details
10/22/2013Q114$0.21$0.18$48.60 million$45.90 millionViewN/AView Earnings Details
7/25/2013Q1 2014$0.23$0.14$49.13 million$43.20 millionViewListenView Earnings Details
4/25/2013Q4 2013$0.26$0.30$52.47 million$50.00 millionViewListenView Earnings Details
1/31/2013Q3 2013$0.20$0.22$45.75 million$49.80 millionViewListenView Earnings Details
10/23/2012$0.18$0.18ViewN/AView Earnings Details
7/26/2012$0.17$0.13ViewN/AView Earnings Details
4/26/2012$0.16$0.21ViewN/AView Earnings Details
1/26/2012$0.16$0.13ViewN/AView Earnings Details
10/25/2011$0.14$0.15ViewN/AView Earnings Details
7/28/2011$0.16$0.10ViewN/AView Earnings Details
4/28/2011$0.16$0.15ViewN/AView Earnings Details
1/27/2011$0.18$0.17ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Abaxis (NASDAQ:ABAX) Earnings Estimates

2017 EPS Consensus Estimate: $1.29
2018 EPS Consensus Estimate: $1.23
2019 EPS Consensus Estimate: $1.25
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.34$0.34$0.34
Q2 20171$0.34$0.34$0.34
Q3 20172$0.29$0.32$0.31
Q4 20172$0.27$0.33$0.30
Q1 20181$0.33$0.33$0.33
Q2 20181$0.38$0.38$0.38
Q3 20181$0.24$0.24$0.24
Q4 20181$0.28$0.28$0.28
Q1 20191$0.28$0.28$0.28
Q2 20191$0.31$0.31$0.31
Q3 20191$0.33$0.33$0.33
Q4 20191$0.33$0.33$0.33
(Data provided by Zacks Investment Research)

Dividends

Abaxis (NASDAQ:ABAX) Dividend Information

Next Dividend:12/15/2017
Annual Dividend:$0.64
Dividend Yield:1.33%
Payout Ratio:53.33% (Trailing 12 Months of Earnings)
59.26% (Based on This Year's Estimates)
51.20% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ:ABAX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/24/2017quarterly$0.161.28%11/30/201712/1/201712/15/2017
7/27/2017quarterly$0.141.19%8/30/20179/1/20179/15/2017
4/27/2017quarterly$0.141.24%5/30/20176/1/20176/15/2017
1/26/2017quarterly$0.141.13%2/27/20173/1/20173/15/2017
10/28/2016quarterly$0.141.17%11/29/201612/1/201612/15/2016
7/21/2016quarterly$0.121.04%8/30/20169/1/20169/15/2016
4/28/2016quarterly$0.121.06%6/1/20166/3/20166/17/2016
1/28/2016quarterly$0.111.01%3/1/20163/3/20163/17/2016
11/3/2015quarterly$0.110.84%12/1/201512/3/201512/17/2015
7/23/2015quarterly$0.110.9%9/1/20159/3/20159/17/2015
4/30/2015quarterly$0.110.79%6/2/20156/4/20156/18/2015
1/30/2015quarterly$0.100.65%2/27/20153/3/20153/17/2015
10/23/2014quarterly$0.100.82%11/13/201411/17/201412/16/2014
7/24/2014quarterly$0.100.86%8/29/20149/3/20149/17/2014
4/24/2014quarterly$0.105/30/20146/3/20146/17/2014
12/6/2012special$1.0012/13/201212/17/201212/28/2012
(Data available from 1/1/2013 forward)

Insider Trades

Abaxis (NASDAQ ABAX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.30%
Institutional Ownership Percentage: 97.68%
Insider Trades by Quarter for Abaxis (NASDAQ:ABAX)
Institutional Ownership by Quarter for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ ABAX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2017Achim HenkelInsiderSell650$48.87$31,765.50View SEC Filing  
5/8/2017Achim HenkelDirectorSell8,650$47.75$413,037.50View SEC Filing  
2/2/2017Richard BastianiDirectorSell4,000$51.12$204,480.00View SEC Filing  
12/6/2016Clinton SeversonCEOSell15,000$51.35$770,250.00View SEC Filing  
12/2/2016Kenneth AronInsiderSell5,000$51.09$255,450.00View SEC Filing  
9/9/2016Clinton SeversonCEOSell2,000$48.29$96,580.00View SEC Filing  
9/8/2016Prithipal SinghDirectorSell1,000$49.50$49,500.00View SEC Filing  
8/25/2016Prithipal SinghDirectorSell1,500$50.30$75,450.00View SEC Filing  
8/24/2016Donald Peter WoodInsiderSell8,500$50.21$426,785.00View SEC Filing  
6/9/2016Richard BastianiDirectorSell5,000$46.75$233,750.00View SEC Filing  
5/17/2016Achim HenkelDirectorSell5,000$44.43$222,150.00View SEC Filing  
5/9/2016Henk EvenhuisDirectorSell3,000$45.00$135,000.00View SEC Filing  
2/9/2016Vernon E AltmanDirectorBuy303$39.87$12,080.61View SEC Filing  
12/8/2015Craig TockmanVPSell560$54.44$30,486.40View SEC Filing  
2/9/2015Prithipal SinghDirectorSell2,500$60.50$151,250.00View SEC Filing  
12/8/2014Kenneth AronCTOSell2,000$56.68$113,360.00View SEC Filing  
11/25/2014Clinton SeversonCEOSell2,286$56.00$128,016.00View SEC Filing  
11/13/2014Clinton SeversonCEOSell10,000$55.00$550,000.00View SEC Filing  
11/5/2014Clinton SeversonCEOSell10,000$54.00$540,000.00View SEC Filing  
11/3/2014Alberto Santa InesCFOSell1,652$53.09$87,704.68View SEC Filing  
11/3/2014Clinton SeversonCEOSell5,000$53.00$265,000.00View SEC Filing  
10/31/2014Clinton SeversonCEOSell10,000$51.50$515,000.00View SEC Filing  
8/12/2014Richard BastianiDirectorSell1,000$45.40$45,400.00View SEC Filing  
7/30/2014Alberto Santa InesCFOSell10,738$47.81$513,383.78View SEC Filing  
7/29/2014Alberto Santa InesCFOSell17,293$48.01$830,236.93View SEC Filing  
6/5/2014Richard BastianiDirectorSell2,000$42.10$84,200.00View SEC Filing  
6/3/2014Richard BastianiDirectorSell4,000$41.88$167,520.00View SEC Filing  
5/22/2014Achim HenkelDirectorSell8,500$41.63$353,855.00View SEC Filing  
5/14/2014Henk EvenhuisDirectorSell4,000$44.06$176,240.00View SEC Filing  
5/1/2014Henk EvenhuisDirectorSell4,500$41.00$184,500.00View SEC Filing  
3/4/2014Vladimir OstoichVPSell9,800$38.53$377,594.00View SEC Filing  
2/24/2014Kenneth AronCTOSell1,000$38.98$38,980.00View SEC Filing  
2/13/2014Donald Peter WoodCOOSell8,864$38.50$341,264.00View SEC Filing  
6/7/2013Clinton SeversonCEOSell10,000$44.50$445,000.00View SEC Filing  
6/7/2013Martin MulroyInsiderSell14,000$44.80$627,200.00View SEC Filing  
5/22/2013Kenneth AronCTOSell4,200$43.28$181,776.00View SEC Filing  
5/7/2013Achim HenkelDirectorSell5,000$44.07$220,350.00View SEC Filing  
3/1/2013Achim HenkelDirectorSell1,000$42.85$42,850.00View SEC Filing  
2/26/2013Martin MulroyInsiderSell12,000$41.84$502,080.00View SEC Filing  
2/5/2013Kenneth AronCTOSell40,000$44.13$1,765,200.00View SEC Filing  
2/4/2013Martin MulroyInsiderSell12,000$43.97$527,640.00View SEC Filing  
11/23/2012Richard BastianiDirectorSell5,000$36.60$183,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Abaxis (NASDAQ ABAX) News Headlines

Source:
DateHeadline
ABAXIS, Inc. (ABAX) Receives Average Recommendation of "Hold" from BrokeragesABAXIS, Inc. (ABAX) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - December 7 at 10:00 PM
Aegis Reiterates Hold Rating for ABAXIS (ABAX)Aegis Reiterates Hold Rating for ABAXIS (ABAX)
www.americanbankingnews.com - December 7 at 7:40 PM
ETFs with exposure to ABAXIS, Inc. : December 6, 2017ETFs with exposure to ABAXIS, Inc. : December 6, 2017
finance.yahoo.com - December 6 at 3:49 PM
ABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : December 6, 2017ABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : December 6, 2017
finance.yahoo.com - December 6 at 11:32 AM
ABAXIS (ABAX) Stock Rating Lowered by Zacks Investment ResearchABAXIS (ABAX) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - December 5 at 3:48 PM
ABAXIS, Inc. :ABAX-US: Earnings Analysis: Q2, 2018 By the Numbers : December 5, 2017ABAXIS, Inc. :ABAX-US: Earnings Analysis: Q2, 2018 By the Numbers : December 5, 2017
finance.yahoo.com - December 5 at 12:52 PM
Q3 2018 Earnings Estimate for ABAXIS, Inc. Issued By Northcoast Research (ABAX)Q3 2018 Earnings Estimate for ABAXIS, Inc. Issued By Northcoast Research (ABAX)
www.americanbankingnews.com - December 4 at 5:32 AM
$0.23 Earnings Per Share Expected for ABAXIS, Inc. (ABAX) This Quarter$0.23 Earnings Per Share Expected for ABAXIS, Inc. (ABAX) This Quarter
www.americanbankingnews.com - December 2 at 7:20 AM
ABAXIS, Inc. : ABAX-US: Dividend Analysis : December 01st, 2017 (record date) : By the numbers : December 1, 2017ABAXIS, Inc. : ABAX-US: Dividend Analysis : December 01st, 2017 (record date) : By the numbers : December 1, 2017
finance.yahoo.com - December 1 at 6:22 PM
Critical Survey: Thoratec (THOR) & ABAXIS (ABAX)Critical Survey: Thoratec (THOR) & ABAXIS (ABAX)
www.americanbankingnews.com - November 27 at 10:58 AM
ABAXIS (ABAX) Up 6.7% Since Earnings Report: Can It Continue?ABAXIS (ABAX) Up 6.7% Since Earnings Report: Can It Continue?
finance.yahoo.com - November 24 at 9:07 AM
Abaxis, Inc. to Present at the 29th Annual Piper Jaffray Healthcare ConferenceAbaxis, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 21 at 3:54 PM
Abaxis (ABAX) Shares Cross Above 200 DMAAbaxis (ABAX) Shares Cross Above 200 DMA
www.nasdaq.com - November 18 at 8:25 PM
Zacks: Analysts Anticipate ABAXIS, Inc. (ABAX) Will Post Quarterly Sales of $56.71 MillionZacks: Analysts Anticipate ABAXIS, Inc. (ABAX) Will Post Quarterly Sales of $56.71 Million
www.americanbankingnews.com - November 15 at 2:34 AM
 Brokerages Expect ABAXIS, Inc. (ABAX) Will Announce Earnings of $0.24 Per Share Brokerages Expect ABAXIS, Inc. (ABAX) Will Announce Earnings of $0.24 Per Share
www.americanbankingnews.com - November 13 at 9:16 PM
ABAXIS, Inc. (ABAX) Receives Consensus Recommendation of "Hold" from AnalystsABAXIS, Inc. (ABAX) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 12 at 10:38 PM
ABAXIS, Inc. (ABAX) Raised to Hold at Zacks Investment ResearchABAXIS, Inc. (ABAX) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - November 12 at 12:58 AM
ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : November 10, 2017ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : November 10, 2017
finance.yahoo.com - November 10 at 8:42 AM
Report: Developing Opportunities within Abaxis, PRA Health Sciences, Brighthouse, Investors Bancorp, Cypress Semiconductor, and Sage Therapeutics – Future Expectations, Projections Moving into 2018Report: Developing Opportunities within Abaxis, PRA Health Sciences, Brighthouse, Investors Bancorp, Cypress Semiconductor, and Sage Therapeutics – Future Expectations, Projections Moving into 2018
finance.yahoo.com - November 6 at 4:03 PM
Abaxis, Inc. to Present at the Credit Suisse 26th Annual Healthcare Conference ...Abaxis, Inc. to Present at the Credit Suisse 26th Annual Healthcare Conference ...
www.prnewswire.com - November 2 at 3:20 PM
Abaxis, Inc. to Present at the Credit Suisse 26th Annual Healthcare Conference, the Canaccord Genuity Medical Technologies & Diagnostics Form 2017 and the Stifel 2017 Healthcare ConferenceAbaxis, Inc. to Present at the Credit Suisse 26th Annual Healthcare Conference, the Canaccord Genuity Medical Technologies & Diagnostics Form 2017 and the Stifel 2017 Healthcare Conference
finance.yahoo.com - November 1 at 3:11 PM
ABAXISs (ABAX) Hold Rating Reaffirmed at Canaccord GenuityABAXIS's (ABAX) Hold Rating Reaffirmed at Canaccord Genuity
www.americanbankingnews.com - October 27 at 6:56 PM
ABAXIS, Inc. (ABAX) to Post Q1 2019 Earnings of $0.28 Per Share, Northcoast Research ForecastsABAXIS, Inc. (ABAX) to Post Q1 2019 Earnings of $0.28 Per Share, Northcoast Research Forecasts
www.americanbankingnews.com - October 27 at 6:54 PM
 Brokerages Expect ABAXIS, Inc. (ABAX) Will Announce Quarterly Sales of $57.86 Million Brokerages Expect ABAXIS, Inc. (ABAX) Will Announce Quarterly Sales of $57.86 Million
www.americanbankingnews.com - October 26 at 5:00 PM
Northcoast Research Research Analysts Decrease Earnings Estimates for ABAXIS, Inc. (ABAX)Northcoast Research Research Analysts Decrease Earnings Estimates for ABAXIS, Inc. (ABAX)
www.americanbankingnews.com - October 26 at 2:09 PM
ETFs with exposure to ABAXIS, Inc. : October 26, 2017ETFs with exposure to ABAXIS, Inc. : October 26, 2017
finance.yahoo.com - October 26 at 11:46 AM
Bullish Two Hundred Day Moving Average Cross - ABAXBullish Two Hundred Day Moving Average Cross - ABAX
www.nasdaq.com - October 25 at 4:07 PM
Edited Transcript of ABAX earnings conference call or presentation 24-Oct-17 8:15pm GMTEdited Transcript of ABAX earnings conference call or presentation 24-Oct-17 8:15pm GMT
finance.yahoo.com - October 25 at 4:07 PM
Abaxis (ABAX) Posts In-Line Earnings in Q2, Lags RevenuesAbaxis (ABAX) Posts In-Line Earnings in Q2, Lags Revenues
finance.yahoo.com - October 25 at 4:07 PM
ABAXIS (ABAX) to Repurchase $21.00 million in   Stock ABAXIS (ABAX) to Repurchase $21.00 million in Stock
www.americanbankingnews.com - October 25 at 11:13 AM
Abaxis Inc. Announces 14% Retreat In Q2 Bottom LineAbaxis Inc. Announces 14% Retreat In Q2 Bottom Line
www.nasdaq.com - October 24 at 8:20 PM
Abaxis Reports Financial Performance for the Second Quarter of Fiscal 2018 and Declares Quarterly Cash DividendAbaxis Reports Financial Performance for the Second Quarter of Fiscal 2018 and Declares Quarterly Cash Dividend
finance.yahoo.com - October 24 at 8:20 PM
ABAXIS, Inc. (ABAX) Raises Dividend to $0.16 Per ShareABAXIS, Inc. (ABAX) Raises Dividend to $0.16 Per Share
www.americanbankingnews.com - October 24 at 5:56 PM
ABAXIS, Inc. (ABAX) Announces  Earnings ResultsABAXIS, Inc. (ABAX) Announces Earnings Results
www.americanbankingnews.com - October 24 at 5:26 PM
ABAXIS, Inc. (ABAX) Expected to Announce Earnings of $0.29 Per ShareABAXIS, Inc. (ABAX) Expected to Announce Earnings of $0.29 Per Share
www.americanbankingnews.com - October 24 at 8:12 AM
American Capital Management Inc Buys Kornit Digital, CyberArk Software, NuVasive Inc, Sells ...American Capital Management Inc Buys Kornit Digital, CyberArk Software, NuVasive Inc, Sells ...
www.nasdaq.com - October 21 at 3:15 PM
ABAXIS (ABAX) versus The Competition Head to Head ContrastABAXIS (ABAX) versus The Competition Head to Head Contrast
www.americanbankingnews.com - October 20 at 12:32 AM
ABAXIS, Inc. (ABAX) Given Average Rating of "Hold" by AnalystsABAXIS, Inc. (ABAX) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - October 19 at 12:38 AM
Abaxis To Report Second Quarter Fiscal Year 2018 Financial Results On Tuesday, October 24, 2017Abaxis To Report Second Quarter Fiscal Year 2018 Financial Results On Tuesday, October 24, 2017
finance.yahoo.com - October 17 at 3:17 PM
ABAXIS, Inc. (ABAX) Set to Announce Quarterly Earnings on MondayABAXIS, Inc. (ABAX) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - October 16 at 5:02 AM
Contrasting Hologic (HOLX) and ABAXIS (ABAX)Contrasting Hologic (HOLX) and ABAXIS (ABAX)
www.americanbankingnews.com - October 16 at 12:08 AM
ABAXIS (ABAX) & Its Competitors Financial ComparisonABAXIS (ABAX) & Its Competitors Financial Comparison
www.americanbankingnews.com - October 13 at 10:28 PM
ETFs with exposure to ABAXIS, Inc. : October 10, 2017ETFs with exposure to ABAXIS, Inc. : October 10, 2017
finance.yahoo.com - October 10 at 3:19 PM
$61.49 Million in Sales Expected for ABAXIS, Inc. (ABAX) This Quarter$61.49 Million in Sales Expected for ABAXIS, Inc. (ABAX) This Quarter
www.americanbankingnews.com - October 7 at 9:38 AM
ABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : October 6, 2017ABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : October 6, 2017
finance.yahoo.com - October 6 at 3:42 PM
ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : October 5, 2017ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : October 5, 2017
finance.yahoo.com - October 5 at 12:38 PM
Abaxis Reaches Analyst Target PriceAbaxis Reaches Analyst Target Price
www.thestreet.com - October 3 at 8:07 PM
ETFs with exposure to ABAXIS, Inc. : September 27, 2017ETFs with exposure to ABAXIS, Inc. : September 27, 2017
finance.yahoo.com - October 2 at 3:07 PM
Contrasting ABAXIS (ABAX) and Its RivalsContrasting ABAXIS (ABAX) and Its Rivals
www.americanbankingnews.com - September 27 at 6:28 PM
Abaxis, Inc. to Present at the Cantor Fitzgerald Global Healthcare ConferenceAbaxis, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 19 at 3:18 PM

SEC Filings

Abaxis (NASDAQ:ABAX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Abaxis (NASDAQ:ABAX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Abaxis (NASDAQ ABAX) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.